针对丙型肝炎病毒RNA(HCV-RNA)的5′非编码区和部分C区的二级结构,设计并合成了四个不同的锤头型核酶(ribozyme A, ribozyme B, ribozyme C1, ribozyme C2).首先应用体外切割实验筛选出作用于HCV-RNA起始密码子上游GTA↓位点的核酶RzA有较好的活性.为初步验证核酶RzA在细胞内的切割活性,经脂质体介导,将RzA-RNA与另一携带该核酶靶基因的质粒表达载体pCl-neo-luciferase(载体中荧光素酶基因受核酶靶基因的调控)共转染HepG2细胞.通过测定荧光素酶基因的表达证实了核酶在细胞内有较好的切割活性.在此实验基础上,把RzA基因克隆至pCl-neo质粒表达载体中,再次经脂质体介导,将重组的表达载体pCl-neo-RzA与携带该核酶靶基因的质粒表达载体pCl-neo-luciferase共转染HepG2细胞,获得了更好的切割效果.
Four kinds of different hammerhead ribozymes (ribozymeA, ribozymeB,ribozymeC1,ribozymeC2) were designed and synthesized according to the secondary structure of HCV-RNA 5′-untranslated region and part of the neighbour C-region. Firstly, the cleavage of the four Rzs were tested in vitro, and only the ribozyme with GTA↓ motif at-11nt site of HCV-RNA showed cleavage activity. RzA-RNA and the combinated pCl-neo-luciferase in which a luciferase gene were ligated downstream the target sequence were then co-transfected into HepG2 cell lines with lipofectine. The cleavage of RzA-RNA was tested by determined the expression of luciferase gene. Therefore, the gene of RzA was ligated into expression vector pCl-neo. This pCl-neo-RzA and the vector pCl-neo-luciferase were co-transfected into HepG2 cell lines again with lipofectine. Since the pCl-neo-RzA was more stable than RzA-RNA in vivo and could produce RzA-RNA continously, it showed better cleavage activity.
刘立忠,王升启,朱宝珍,孙志贤.丙型肝炎病毒RNA特异性核酶的切割活性研究[J].生物化学与生物物理进展,1998,25(5):449-453
复制生物化学与生物物理进展 ® 2025 版权所有 ICP:京ICP备05023138号-1 京公网安备 11010502031771号